Journal articles on the topic 'Time-Of-Day administration of immunotherapy'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Time-Of-Day administration of immunotherapy.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Arroyave Ramirez, Andres Mauricio, Daniel Motola, Mariana Guadalupe Morales Garcia, and Emilio Conde-Flores. "Impact of time-of-day administration of immunotherapy on overall survival among patients with metastatic renal cell carcinoma." Journal of Clinical Oncology 42, no. 16_suppl (June 1, 2024): e16537-e16537. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.e16537.
Full textOrtego, Ignacio, Javier Molina-Cerrillo, Alvaro Pinto, Matteo Santoni, Teresa Alonso-Gordoa, M. Pilar Lopez Criado, Alejandro Gonzalez-Morales, and Enrique Grande. "Time-of-day infusion of immunotherapy in metastatic urothelial cancer (mUC): Should it be considered to improve survival outcomes?" Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): e16541-e16541. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e16541.
Full textDougherty, David W., Houry Leblebjian, Megan Duperrault, Mark M. Awad, Sylvia Bartel, Anne McDonnell, Craig A. Bunnell, et al. "Outcomes of immunotherapy administration for hospitalized cancer patients." Journal of Clinical Oncology 37, no. 27_suppl (September 20, 2019): 98. http://dx.doi.org/10.1200/jco.2019.37.27_suppl.98.
Full textLeblebjian, Houry, Megan Duperrault, Brett Glotzbecker, Mark M. Awad, Sylvia Bartel, Anne McDonnell, Craig A. Bunnell, Andrew J. Wagner, Lauren M. Hamel, and David W. Dougherty. "Outcomes of immunotherapy administration for hospitalized cancer patients." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e18225-e18225. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e18225.
Full textJudd, Courtney A., Amy L. Parker, Eric A. Meier, and Michael S. Tankersley. "Successful administration of a 1-day imported fire ant rush immunotherapy protocol." Annals of Allergy, Asthma & Immunology 101, no. 3 (September 2008): 311–15. http://dx.doi.org/10.1016/s1081-1206(10)60497-8.
Full textDvorak, Tomas, Thomas T. Maroney, Srujankumar Dhannapuneni, Ian Stephenson, and Amy Iarrobino Laughlin. "Assessment of outpatient chemotherapy and unplanned emergency department visits in a large community hospital system." Journal of Clinical Oncology 41, no. 16_suppl (June 1, 2023): e18768-e18768. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e18768.
Full textLissoni, Paolo, Sofia Meregalli, Vittorio Fossati, Franco Paolorossi, Sandro Barni, Gabriele Tancini, and Franco Frigerio. "A Randomized Study of Immunotherapy with Low-Dose Subcutaneous Interleukin-2 plus Melatonin Vs Chemotherapy with Cisplatin and Etoposide as First-Line Therapy for Advanced Non-Small Cell Lung Cancer." Tumori Journal 80, no. 6 (December 1994): 464–67. http://dx.doi.org/10.1177/030089169408000611.
Full textTsimafeyeu, I. V. "Nivolumab: 5 years from the day of international registration of immunotherapy of metastatic kidney cancer." Malignant tumours 10, no. 4 (July 7, 2021): 21–29. http://dx.doi.org/10.18027/2224-5057-2020-10-4-21-29.
Full textSenti, Gabriela, Bettina M. Prinz Vavricka, Iris Erdmann, Mella I. Diaz, Richard Markus, Stephen J. McCormack, John J. Simard, et al. "Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial." Proceedings of the National Academy of Sciences 105, no. 46 (November 10, 2008): 17908–12. http://dx.doi.org/10.1073/pnas.0803725105.
Full textLin, Lin, Ashraf S. Ibrahim, Beverlie Baquir, Andrew Palosaari, and Brad Spellberg. "Real-time tracking ATAK cells in vivo (52.1)." Journal of Immunology 186, no. 1_Supplement (April 1, 2011): 52.1. http://dx.doi.org/10.4049/jimmunol.186.supp.52.1.
Full textDenis, Michel, and Esfandiar Ghadirian. "Immunotherapy of Airborne Tuberculosis in Mice Via the Lung-Specific Delivery of Cytokines." Canadian Journal of Infectious Diseases 4, no. 1 (1993): 38–42. http://dx.doi.org/10.1155/1993/954372.
Full textHe, Shuyang, Joseph Gleason, Nassir Habboubi, Robert Hariri, and Xiaokui Zhang. "EXTH-16. HUMAN PLACENTAL HEMATOPOIETIC STEM CELL DERIVED NATURAL KILLER CELLS FOR GLIOBLASTOMA IMMUNOTHERAPY." Neuro-Oncology 21, Supplement_6 (November 2019): vi85. http://dx.doi.org/10.1093/neuonc/noz175.350.
Full textKhatibi, Azadeh Sharif, Nasim Hayati Roodbari, Keivan Majidzade-A, Parichehreh Yaghmaei, and Leila Farahmand. "In vivo tumor-suppressing and anti-angiogenic activities of a recombinant anti-CD3ε nanobody in breast cancer mice model." Immunotherapy 11, no. 18 (December 2019): 1555–67. http://dx.doi.org/10.2217/imt-2019-0068.
Full textMarino, Patricia, Rajae Touzani, Myriam Palomares, Maria-Antonietta Cappiello, Anne Deborah Bouhnik, Najoua Guelmani, Magali Provansal, et al. "Phone call for chemotherapy validation in outpatient unit as a way to optimize health care without compromising patients' satisfaction and quality of life." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): 6588. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.6588.
Full textAna Margarida, Mesquita, Coutinho Ricardo Moço, Plácido José Luís, and Coimbra Alice. "Impact of coronavirus pandemic on safety and time of administration of subcutaneous immunotherapy among pediatric patients." Journal of Child, Adult Vaccines and Immunology 6, no. 1 (September 2, 2022): 001–4. http://dx.doi.org/10.29328/journal.jcavi.1001008.
Full textParker, A. L., E. A. Meier, and L. L. Hagan. "Successful administration of a one-day imported fire ant (IFA) rush immunotherapy protocol in two children." Journal of Allergy and Clinical Immunology 115, no. 2 (February 2005): S99. http://dx.doi.org/10.1016/j.jaci.2004.12.411.
Full textAtallah, Aline, Arielle Grossman, Jean-Francois Pare, Robert Siemens, Tiziana Cotechini, and Charles H. Graham. "Abstract 3540: Effect of route of Bacillus Calmette Guerin administration on the immune microenvironment and growth of bladder tumors." Cancer Research 82, no. 12_Supplement (June 15, 2022): 3540. http://dx.doi.org/10.1158/1538-7445.am2022-3540.
Full textZhang, Jing, Xue Zhou, Yuming Jia, Shenglan Huang, Qiu Wang, Mao-Qiong Jiang, Ting Li, et al. "Prevention of pemetrexed-induced rash with low-dose dexamethasone in patients with NSCLC receiving immunotherapy: A prospective, single-arm clinical trial." Journal of Clinical Oncology 42, no. 16_suppl (June 1, 2024): e20596-e20596. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.e20596.
Full textChataway, Jeremy, Keith Martin, Kevin Barrell, Basil Sharrack, Pelle Stolt, and David C. Wraith. "Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosis." Neurology 90, no. 11 (February 21, 2018): e955-e962. http://dx.doi.org/10.1212/wnl.0000000000005118.
Full textQuiralte, Joaquín, María Angeles Lara, Gemma Vanesa Sánchez, Javier Monteserín, Luís Fernández, María Cruz Gómez-Fernández, Begoña Madariaga, et al. "Tolerability and surrogate efficacy parameters of a polymerized depot mixture pollen extracts without dilutional effect." Immunotherapy 11, no. 12 (August 2019): 1031–42. http://dx.doi.org/10.2217/imt-2019-0051.
Full textJablons, D., E. Bolton, S. Mertins, M. Rubin, P. Pizzo, S. A. Rosenberg, and M. T. Lotze. "IL-2-based immunotherapy alters circulating neutrophil Fc receptor expression and chemotaxis." Journal of Immunology 144, no. 9 (May 1, 1990): 3630–36. http://dx.doi.org/10.4049/jimmunol.144.9.3630.
Full textBarba, David, Stephen C. Saris, Carol Holder, Steven A. Rosenberg, and Edward H. Oldfield. "Intratumoral LAK cell and interleukin-2 therapy of human gliomas." Journal of Neurosurgery 70, no. 2 (February 1989): 175–82. http://dx.doi.org/10.3171/jns.1989.70.2.0175.
Full textBarlow, Brett, Haris Hatic, Charles Douglas Bodine, Amitkumar Mehta, Gaurav Goyal, and Mayur Narkhede. "Safety of same day HD-MTX with induction therapy for DLBCL with concurrent CNS disease or as prophylaxis for high risk of CNS relapse." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): e19545-e19545. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e19545.
Full textShevela, E. Ya, V. G. Degtyareva, A. V. Sosnovskaya, E. V. Voronova, M. Yu Kafanova, I. M. Rashchupkin, A. A. Ostanin, and E. R. Chernykh. "Therapeutic effect of soluble factors of M2 phenotype macrophages in children with language impairments." Medical Immunology (Russia) 23, no. 5 (November 17, 2021): 1137–50. http://dx.doi.org/10.15789/1563-0625-teo-2224.
Full textBallas, Z. K. "Lymphokine-activated killer (LAK) cells. I. Differential recovery of LAK, natural killer cells, and cytotoxic T lymphocytes after a sublethal dose of cyclophosphamide." Journal of Immunology 137, no. 7 (October 1, 1986): 2380–84. http://dx.doi.org/10.4049/jimmunol.137.7.2380.
Full textSantoni, Matteo, Javier Molina-Cerrillo, Giorgio Santoni, Elaine T. Lam, Francesco Massari, Veronica Mollica, Giulia Mazzaschi, Bernardo L. Rapoport, Enrique Grande, and Sebastiano Buti. "Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic Consequences." Cancers 15, no. 2 (January 7, 2023): 408. http://dx.doi.org/10.3390/cancers15020408.
Full textGonçalves, Lisa, Duarte Goncalves, Teresa Esteban Casanelles, Laura Pratas Guerra, Maria B. Menezes, Vanessa Duarte Branco, Joana Alves Luís, et al. "Retro TIMing: A multicentric retrospective analysis of immunotherapy timing in metastatic melanoma." Journal of Clinical Oncology 42, no. 16_suppl (June 1, 2024): 9542. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.9542.
Full textRykov, M. Yu, and I. S. Dolgopolov. "Experience in the use of dendritic vaccines in the treatment of patients with recurrent gliomas." Research and Practical Medicine Journal 9, no. 4 (December 1, 2022): 18–29. http://dx.doi.org/10.17709/2410-1893-2022-9-4-2.
Full textFletcher, James, Sebastian Kang, Amy Brown, Sabe S. Sabesan, Megan Lyle, Ritwik Pandey, Andrew Lui, et al. "Administration of immune checkpoint inhibitors using teleoncology model of care in Far North Queensland: A multicenter review of safety outcomes." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 2084. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.2084.
Full textHo, Jeremy, Antonia Susnjar, Jessica Rhudy, Antons Sizovs, Graziano Lolli, Ramiro Pino, Corrine Ying Xuan Chua, E. Brian Butler, Sandra Demaria, and Alessandro Grattoni. "Localizing radioimmunotherapy via nanochannel device for sustained intratumoral drug delivery for solid tumor treatment." Journal of Clinical Oncology 37, no. 8_suppl (March 10, 2019): 37. http://dx.doi.org/10.1200/jco.2019.37.8_suppl.37.
Full textYatsenko, Elena M., Denis S. Baranovsky, Marianna D. Pronkevich, Elena V. Isaeva, Anna N. Smirnova, Vasiliy N. Petrov, Sergey A. Ivanov, and Andrey D. Kaprin. "EFFECTS OF THE IMMUNOMODULATOR ‘GALAVIT’ ON THE DEVELOPMENT OF B16 MELANOMA IN MICE." Siberian Journal of Life Sciences and Agriculture 15, no. 2 (April 30, 2023): 454–69. http://dx.doi.org/10.12731/2658-6649-2023-15-2-454-469.
Full textTritarelli, E., E. Rocca, U. Testa, G. Boccoli, A. Camagna, F. Calabresi, and C. Peschle. "Adoptive immunotherapy with high-dose interleukin-2: kinetics of circulating progenitors correlate with interleukin-6, granulocyte colony-stimulating factor level." Blood 77, no. 4 (February 15, 1991): 741–49. http://dx.doi.org/10.1182/blood.v77.4.741.741.
Full textTritarelli, E., E. Rocca, U. Testa, G. Boccoli, A. Camagna, F. Calabresi, and C. Peschle. "Adoptive immunotherapy with high-dose interleukin-2: kinetics of circulating progenitors correlate with interleukin-6, granulocyte colony-stimulating factor level." Blood 77, no. 4 (February 15, 1991): 741–49. http://dx.doi.org/10.1182/blood.v77.4.741.bloodjournal774741.
Full textZhukova, N. V., R. V. Orlova, Ye A. Kaledina, A. M. Malkova, P. A. Naymushina, N. P. Belyak, and A. S. Demchenkova. "Immunotherapy of Metastatic Melanoma Yesterday, Today, Tomorrow." Effective Pharmacotherapy 17, no. 11 (May 29, 2021): 22–28. http://dx.doi.org/10.33978/2307-3586-2021-17-11-22-28.
Full textAckerstein, A., E. Kedar, and S. Slavin. "Use of recombinant human interleukin-2 in conjunction with syngeneic bone marrow transplantation in mice as a model for control of minimal residual disease in malignant hematologic disorders." Blood 78, no. 5 (September 1, 1991): 1212–15. http://dx.doi.org/10.1182/blood.v78.5.1212.1212.
Full textAckerstein, A., E. Kedar, and S. Slavin. "Use of recombinant human interleukin-2 in conjunction with syngeneic bone marrow transplantation in mice as a model for control of minimal residual disease in malignant hematologic disorders." Blood 78, no. 5 (September 1, 1991): 1212–15. http://dx.doi.org/10.1182/blood.v78.5.1212.bloodjournal7851212.
Full textMirsoian, Annie, Myriam N. Bouchlaka, Gail Sckisel, Mingyi Chen, Chien-Chun Steven Pai, Emanuel Maverakis, Richard Spencer, et al. "Adiposity As a Principal Component of Lethal Cytokine Storm Following Cancer Immunotherapy in Aged Mice." Blood 124, no. 21 (December 6, 2014): 460. http://dx.doi.org/10.1182/blood.v124.21.460.460.
Full textZhang, Zhipeng, Ningning Liu, and Mingyu Sun. "Research Progress of Immunotherapy for Gastric Cancer." Technology in Cancer Research & Treatment 22 (January 2023): 153303382211505. http://dx.doi.org/10.1177/15330338221150555.
Full textIlonidis, G., G. Anogianakis, Chr Trakatelli, A. Anogeianaki, J. Giavazis, M. Trakatellis, and I. Michalis. "The Effects of Long-Term Treatment by Immunotherapy and Fluticazone on Broncial Hyperreactivity." European Journal of Inflammation 1, no. 1 (January 2003): 13–16. http://dx.doi.org/10.1177/1721727x0300100104.
Full textGriffiths, Robert, Mark Danese, Michelle Gleeson, and Kevin Knopf. "Patterns of Chemotherapy/Immunotherapy and Survival in Mantle Cell Lymphoma: Evidence from SEER-Medicare." Blood 112, no. 11 (November 16, 2008): 5293. http://dx.doi.org/10.1182/blood.v112.11.5293.5293.
Full textZeter, Daniel, and Ina J. Patel. "Immunotherapy-related toxicities: A retrospective analysis of barriers to prompt detection and initiation of treatment in renal cell carcinoma." Journal of Clinical Oncology 41, no. 16_suppl (June 1, 2023): e16547-e16547. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e16547.
Full textMatysiak, Joanna, Eliza Matuszewska, Marek L. Kowalski, Sławomir W. Kosiński, Ewa Smorawska-Sabanty, and Jan Matysiak. "Association between Venom Immunotherapy and Changes in Serum Protein—Peptide Patterns." Vaccines 9, no. 3 (March 12, 2021): 249. http://dx.doi.org/10.3390/vaccines9030249.
Full textMayrink, W., P. A. Magalhaes, and M. S. M. Michalick. "IMMUNOTHERAPY AS A TREATMENT OF AMERICAN CUTANEOUS LEISHMANIASIS: PRELIMINARY STUDIES IN BRAZIL." Pediatrics 95, no. 6 (June 1, 1995): 891. http://dx.doi.org/10.1542/peds.95.6.891.
Full textBlethen, Kathryn, Samuel Sprowls, Tasneem Arsiwala, Cullen Wolford, Dhruvi Panchal, Ross Fladeland, Morgan Glass, et al. "BSBM-11 COMBINING IMMUNOTHERAPY AND WHOLE-BRAIN RADIATION THERAPY IN A NOVEL SYNGENEIC LUNG CANCER BRAIN METASTASIS PRECLINICAL MODEL: DOES TIMING OF ADMINISTRATION MATTER?" Neuro-Oncology Advances 5, Supplement_3 (August 1, 2023): iii2—iii3. http://dx.doi.org/10.1093/noajnl/vdad070.007.
Full textMarté, Jennifer L., Nicole J. Toney, Lisa Cordes, Jeffrey Schlom, Renee N. Donahue, and James L. Gulley. "Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management." Journal for ImmunoTherapy of Cancer 8, no. 2 (November 2020): e001019. http://dx.doi.org/10.1136/jitc-2020-001019.
Full textCiprandi, Giorgio, Matteo Naso, and Maria Angela Tosca. "Tablet allergen immunotherapy." Allergologia et Immunopathologia 52, no. 3 (May 1, 2024): 73–77. http://dx.doi.org/10.15586/aei.v52i3.990.
Full textLeyva-Grado, Victor H., Gene S. Tan, Paul E. Leon, Mark Yondola, and Peter Palese. "Direct Administration in the Respiratory Tract Improves Efficacy of Broadly Neutralizing Anti-Influenza Virus Monoclonal Antibodies." Antimicrobial Agents and Chemotherapy 59, no. 7 (May 4, 2015): 4162–72. http://dx.doi.org/10.1128/aac.00290-15.
Full textDolgopolov, I. S., and M. Yu Rykov. "Immunotherapy for children with malignant brain tumors." Russian Journal of Immunology 27, no. 1 (August 6, 2024): 85–94. http://dx.doi.org/10.46235/1028-7221-16566-ifc.
Full textFell, William R., Richard L. Mabry, and Cynthia S. Mabry. "Quality of Life Analysis of Patients Undergoing Immunotherapy for Allergic Rhinitis." Ear, Nose & Throat Journal 76, no. 8 (August 1997): 528–36. http://dx.doi.org/10.1177/014556139707600809.
Full textPoirier, Marie-Denise, Houda Haban, and Abdeljabar El Andaloussi. "A Combination of Systemic and Intracranial Anti-CD25 Immunotherapy Elicits a Long-Time Survival in Murine Model of Glioma." Journal of Oncology 2009 (2009): 1–8. http://dx.doi.org/10.1155/2009/963037.
Full text